🔎 Trials Near Me

Akèy › Kansè Poumon ki pa ti selil › Michigan › Dearborn

Etid klinik pou Kansè Poumon ki pa ti selil nan Dearborn, MI

6 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Dearborn (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ap rekriteFaz 3
  • Corewell Health Dearborn Hospital, Dearborn
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04267848

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Ap rekriteFaz 2
  • Michigan Hematology and Oncology Consultants, Dearborn
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT06463665

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Henry Ford Medical Center-Fairlane, Dearborn
  • Henry Ford Wyandotte Hospital, Wyandotte · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Henry Ford Medical Center-Fairlane, Dearborn
  • Henry Ford Wyandotte Hospital, Wyandotte · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06116682

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Ap rekriteFaz 2
  • Michigan Hematology & Oncology Consultants - MedOnc Dearborn, Dearborn
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2024 · NCT06281678

Etid Kansè Poumon ki pa ti selil nan lòt vil

Lòt etid nan Dearborn

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.